Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells

Background: Multiple myeloma (MM) is the second most common hematological cancer after lymphoma. It is characterized by the accumulation of clonal malignant plasma cells within the bone marrow. The development of drug resistance remains a major problem for effective treatment of MM. Understand the m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Gourzones, Claire, Bellanger, Céline, Lamure, Sylvain, Gadacha, Ouissem Karmous, De Paco, Elvira Garcia, Vincent, Laure, Cartron, Guillaume, Klein, Bernard, Moreaux, Jérôme
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6521290/
https://ncbi.nlm.nih.gov/pubmed/30925767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11040439
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados